ZIMMER BIOMET HOLDINGS INC (ZBH) Stock Analyst Earnings Estimates
NYSE:ZBH - New York Stock Exchange, Inc. - US98956P1021 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 6.94B 1.65% | 7.394B 6.55% | 7.679B 3.85% | 8.266B 7.65% | 8.731B 5.63% | 9.124B 4.50% | 9.454B 3.62% | 9.852B 4.21% | 11.01B 11.75% | 10.324B -6.23% | 10.744B 4.07% | |
| EBITDA YoY % growth | 2.152B 7.84% | 2.425B 12.65% | 2.555B 5.38% | 2.881B 12.75% | 2.959B 2.71% | 3.105B 4.93% | 3.249B 4.64% | 3.528B 8.59% | 3.714B 5.27% | N/A | N/A | |
| EBIT YoY % growth | 1.226B 15.85% | 1.473B 20.15% | 1.559B 5.83% | 2.217B 42.22% | 2.301B 3.79% | 2.44B 6.04% | 2.623B 7.50% | 2.817B 7.40% | 3.074B 9.12% | N/A | N/A | |
| Operating Margin | 17.66% | 19.92% | 20.30% | 26.82% | 26.35% | 26.74% | 27.74% | 28.59% | 27.92% | N/A | N/A | |
| EPS YoY % growth | 6.89 -6.51% | 7.56 9.72% | 8.00 5.82% | 8.05 0.60% | 8.40 4.35% | 9.22 9.82% | 9.65 4.64% | 10.57 9.51% | 12.42 17.55% | N/A | N/A |
All data in USD
| Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 2.00 -0.32% | 1.84 5.83% | 2.37 2.52% | 1.89 4.31% | 2.22 10.97% | 2.11 14.34% | 2.57 8.39% | 2.14 13.59% | 2.34 5.26% | 2.29 8.99% | 2.69 4.64% |
| Revenue Q2Q % growth | 2.073B 6.75% | 2.009B 10.13% | 2.251B 11.26% | 2.082B 9.06% | 2.098B 1.21% | 1.996B -0.65% | 2.216B -1.55% | 2.077B -0.24% | 2.155B 2.72% | 2.061B 3.26% | 2.288B 3.25% |
| EBITDA Q2Q % growth | 713.98M -19.16% | 675.85M -35.79% | 802.6M -44.35% | 696.99M 17.06% | 746.07M 4.49% | 719.24M 6.42% | 837.15M 4.30% | 768.46M 10.25% | 797.01M 6.83% | 801.09M 11.38% | 857.79M 2.47% |
| EBIT Q2Q % growth | 568.69M 41.68% | 530.32M 65.78% | 660M 48.05% | 535.1M 56.92% | 603.28M 6.08% | 575.99M 8.61% | 695.3M 5.35% | 602.85M 12.66% | 630.91M 4.58% | 634.26M 10.12% | 701.97M 0.96% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2025 Q2Q % growth | 1.81 -6.70% | 1.79 | 0.02 | 1.25% |
| Q4 2024 Q2Q % growth | 2.31 5.00% | 2.32 | -0.01 | -0.34% |
| Q3 2024 Q2Q % growth | 1.74 5.45% | 1.75 | -0.01 | -0.70% |
| Q2 2024 Q2Q % growth | 2.01 10.44% | 2.01 | 0.00 | 0.07% |
| Q1 2024 Q2Q % growth | 1.94 2.65% | 1.89 | 0.05 | 2.75% |
| Q4 2023 Q2Q % growth | 2.20 17.02% | 2.18 | 0.02 | 1.10% |
| Q3 2023 Q2Q % growth | 1.65 4.43% | 1.61 | 0.04 | 2.25% |
| Q2 2023 Q2Q % growth | 1.82 | 1.83 | -0.01 | -0.43% |
| Q1 2023 Q2Q % growth | 1.89 17.39% | 1.66 | 0.23 | 14.18% |
| Q4 2022 Q2Q % growth | 1.88 -3.59% | 1.84 | 0.04 | 1.90% |
| Q3 2022 Q2Q % growth | 1.58 -12.71% | 1.57 | 0.01 | 0.60% |
| Q2 2022 Q2Q % growth | 1.82 -4.21% | 1.66 | 0.16 | 9.51% |
| Q1 2022 Q2Q % growth | 1.61 -5.85% | 1.42 | 0.19 | 13.19% |
| Q4 2021 Q2Q % growth | 1.95 -7.58% | 2.00 | -0.05 | -2.37% |
| Q3 2021 Q2Q % growth | 1.81 | 1.77 | 0.04 | 2.00% |
| Q2 2021 Q2Q % growth | 1.90 3,700.00% | 1.89 | 0.01 | 0.70% |
| Q1 2021 Q2Q % growth | 1.71 0.59% | 1.55 | 0.16 | 10.60% |
| Q4 2020 Q2Q % growth | 2.11 -8.26% | 2.08 | 0.03 | 1.56% |
| Q3 2020 Q2Q % growth | 1.81 2.26% | 1.08 | 0.73 | 68.03% |
| Q2 2020 Q2Q % growth | 0.05 -97.41% | -0.74 | 0.79 | 106.77% |
| Q1 2020 Q2Q % growth | 1.70 -9.09% | 1.40 | 0.30 | 21.74% |
| Q4 2019 Q2Q % growth | 2.30 | 2.29 | 0.01 | 0.45% |
| Q3 2019 Q2Q % growth | 1.77 | 1.77 | 0.00 | 0.01% |
| Q2 2019 Q2Q % growth | 1.93 | 1.93 | 0.00 | -0.15% |
| Q1 2019 Q2Q % growth | 1.87 | 1.88 | -0.01 | -0.64% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2025 Q2Q % growth | 1.909B 1.05% | 1.914B | -4.9M | -0.26% |
| Q4 2024 Q2Q % growth | 2.023B 4.28% | 2.034B | -10.8M | -0.53% |
| Q3 2024 Q2Q % growth | 1.824B 4.03% | 1.813B | 11.2M | 0.62% |
| Q2 2024 Q2Q % growth | 1.942B 3.87% | 1.96B | -18M | -0.92% |
| Q1 2024 Q2Q % growth | 1.889B 3.18% | 1.888B | 1.2M | 0.06% |
| Q4 2023 Q2Q % growth | 1.94B 6.30% | 1.946B | -5.9M | -0.30% |
| Q3 2023 Q2Q % growth | 1.754B 5.02% | 1.768B | -14.4M | -0.81% |
| Q2 2023 Q2Q % growth | 1.87B 4.93% | 1.843B | 26.6M | 1.44% |
| Q1 2023 Q2Q % growth | 1.831B 10.09% | 1.721B | 110M | 6.39% |
| Q4 2022 Q2Q % growth | 1.825B 2.70% | 1.779B | 46.1M | 2.59% |
| Q3 2022 Q2Q % growth | 1.67B -0.93% | 1.651B | 18.8M | 1.14% |
| Q2 2022 Q2Q % growth | 1.782B 1.05% | 1.738B | 43.8M | 2.52% |
| Q1 2022 Q2Q % growth | 1.663B -9.97% | 1.601B | 62.2M | 3.89% |
| Q4 2021 Q2Q % growth | 1.777B -14.77% | 2.088B | -310.8M | -14.89% |
| Q3 2021 Q2Q % growth | 1.685B -12.64% | 1.962B | -276.6M | -14.10% |
| Q2 2021 Q2Q % growth | 1.763B 43.81% | 1.998B | -234.7M | -11.75% |
| Q1 2021 Q2Q % growth | 1.847B 3.57% | 1.776B | 71.4M | 4.02% |
| Q4 2020 Q2Q % growth | 2.085B -1.90% | 2.102B | -16.7M | -0.79% |
| Q3 2020 Q2Q % growth | 1.929B 1.95% | 1.728B | 201.3M | 11.65% |
| Q2 2020 Q2Q % growth | 1.226B -38.34% | 918.5M | 307.6M | 33.49% |
| Q1 2020 Q2Q % growth | 1.784B -9.70% | 1.835B | -51.2M | -2.79% |
| Q4 2019 Q2Q % growth | 2.126B | 2.128B | -2.3M | -0.11% |
| Q3 2019 Q2Q % growth | 1.892B | 1.892B | 400K | 0.02% |
| Q2 2019 Q2Q % growth | 1.989B | 2.001B | -12.4M | -0.62% |
| Q1 2019 Q2Q % growth | 1.976B | 1.983B | -7.5M | -0.38% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -0.09% | -2.15% | 0.03% | -2.97% |
| Revenue | -0.05% | 3.34% | 0% | 3.69% |